Activity Description
In 15 minutes, you can watch this on-demand, case discussion about Susan from the proceedings of a Women’s Health Issues CE course held on April 30, 2016, in Pasadena, California. Learn about:
- How to begin the weight-loss conversation with your overweight and obese female patients
- How to individualize weight-loss and maintenance programs for your overweight and obese female patients
Learning Objectives
Upon completion of this activity, learners should be able to:
- Apply communication strategies to initiate and implement weight-management programs for overweight and obese female patients
- Individualize weight-loss maintenance programs for overweight and obese female patients based on patient factors
Faculty
Mary Annette Hess, PhD, CRNP, FNP-BC
Assistant Professor/Family Nurse Practitioner
University of Alabama at Birmingham
School of Nursing
Birmingham, AL
Faculty Biography
Mary Annette Hess, PhD, CRNP, FNP-BC
Mary Annette Hess, PhD, CRNP, FNP-BC, is an Assistant Professor at the University of Alabama (UAB) School of Nursing in Birmingham, and an Affiliate Member of the graduate faculty at the University of Alabama in Huntsville. She received her BSN degree at Auburn University at Montgomery in Alabama and her MSN degree in nursing education at Troy State University in Alabama. Dr Hess went on to complete a post-MSN family nurse practitioner degree and a PhD in health education and health promotion at UAB Birmingham.
Dr Hess is an active researcher in the prevention and management of prediabetes, diabetes, dyslipidemia, obesity, and diabetes outcomes, and is currently a Co-investigator of the National Institutes of Health (NIH)-sponsored ENCOURAGE-1 and ENCOURAGE- 2 (iAdapt) studies. She is author or co-author of numerous books, book chapters, and journal articles, and has presented her research at several national meetings. She is Chair for the School of Nursing (SON) Faculty Practice Committee and a member of the SON Executive Committee. Dr Hess also serves as an educational member for the National Association of Nurse Practitioners in Women’s Health and Gerontological Advanced Practice Nurses Association. In addition, she is on the board of directors for Southeastern Diabetes Education Services.
Disclosure Statements
Nurse Practitioners in Women’s Health (NPWH) policy requires all faculty to disclose any affiliation or relationship with a commercial interest that may cause a potential, real, or apparent conflict of interest with the content of a CE program. NPWH does not imply that the affiliation or relationship will affect the content of the CE program. Disclosure provides participants with information that may be important to their evaluation of an activity.
Conflicts of interest were resolved according to NPWH policy prior to development of content.
NPWH policy requires authors to disclose to the participant when presenting information about unlabeled use of any commercial product or device or an investigational use of a drug or device not yet approved for any use.
Faculty
Mary Annette Hess, PhD, CRNP, FNP-BC
Dr Hess has no disclosures to be made.
Educational Planning Committee
Spire Learning
Jaime Symowicz, PhD, Lauren Waters, and Lisa Conklin have nothing to disclose.
National Association of Nurse Practitioners in Women’s Health
Gay Johnson and Susan Rawlins, MS, WHNP-BC, NP, have nothing to disclose.
Disclaimer
The participating faculty determines the editorial content of the CE activity and the content does not necessarily represent the views of NPWH or Spire Learning. This content has been peer reviewed for validation of clinical content. While every effort has been made to ensure that the information is accurate, clinicians are responsible for evaluating this information in relation to generally accepted standards in their own communities and integrating the information in this activity with those of established recommendations of other authorities, national guidelines, FDA-approved package inserts, and individual patient characteristics.
Off-label Statement
This educational activity does not contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Levels of Evidence
The following levels of evidence are provided for any patient care recommendations made in this presentation and are denoted by a superscript A, B, or C.
Strength of Recommendation
- Level A: supported by sufficient, consistent scientific evidence (eg, multiple, randomized clinical trials or meta-analyses)
- Level B: supported by limited or inconsistent evidence (eg, nonrandomized trials or single randomized trial)
- Level C: based primarily on expert opinion
Target Audience
This activity is designed for healthcare professionals with an interest in the management of women’s health, including women’s health nurse practitioners, adult nurse practitioners, family nurse practitioners, certified nurse midwives, and other advanced practice clinicians.
Accreditation
This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for 0.25 contact hours of continuing education. Each participant should claim only those contact hours actually spent in the educational activity.
Method of Participation
This activity has no fee and should take approximately 25 minutes to complete. Participants should first read the objectives and other introductory CE information, then complete the pre-assessment and participate in the online activity. To receive credit for this activity, participants must complete the postassessment with a passing score of 70% and then complete the evaluation. This credit is valid through October 19, 2017. No credit will be given after this date. In the event you have questions about this activity or are unable to print the certificate, please email Lauren Waters at lwaters@spirelearning.com, and a certificate will be emailed within 2 weeks.
This educational activity is jointly provided by the National Association of Nurse Practitioners in Women’s Health and Spire Learning.
This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc. U.S. Region, Teva Pharmaceuticals, and Shionogi, Inc.